Antibiotic Selection in Chronic Liver Disease with Acute Kidney Injury

Introduction to Antibiotic Selection

• The American Association for the Study of Liver Diseases recommends initiating broad-spectrum antibiotics immediately when infection is suspected in patients with chronic liver disease and acute kidney injury, selecting agents based on infection source, local resistance patterns, and where the infection was acquired, while strictly avoiding nephrotoxic agents and adjusting doses for renal function 1

Immediate Antibiotic Initiation Strategy

• The American Association for the Study of Liver Diseases suggests that first doses of antibiotics must be administered in the emergency room without delay, as each hour of delay increases mortality in patients with acute-on-chronic liver failure 1
• The pharmacist should minimize salt load with antibiotic administration given the fluid-sensitive nature of these patients 1

Critical Pre-Treatment Steps

• Obtain cultures before starting antibiotics to guide de-escalation, as recommended by the American Association for the Study of Liver Diseases and other guideline societies 1, 2
• Identify and discontinue all nephrotoxic medications immediately, as each nephrotoxin increases AKI odds by 53%, and combining multiple nephrotoxins more than doubles AKI risk, according to the European Renal Association 3, 2

Antibiotic Selection Algorithm

• For community-acquired infections, use standard first-line agents with renal dose adjustment, as recommended by the American Association for the Study of Liver Diseases 1
• For healthcare-associated or nosocomial infections, require broader coverage due to multidrug-resistant organism risk, according to the American Association for the Study of Liver Diseases 1

Renal Function-Based Dose Adjustments

• For GFR 50-80 ml/min, levofloxacin dosage is 500 mg loading dose, then 250 mg every 24 hours, as recommended by the National Kidney Foundation 4
• For GFR 30-50 ml/min, macrolides should be reduced by 50%, according to the National Kidney Foundation 4

Monitoring and De-escalation

• Culture results should trigger immediate antibiotic de-escalation to decrease multidrug-resistant colonization risk, as recommended by the American Association for the Study of Liver Diseases 1
• Treat for the shortest reasonable duration (generally ≤7 days for UTI), according to the Infectious Diseases Society of America 2

Special Considerations

• Fungal infections occur in 2-16% of acute-on-chronic liver failure patients, almost always nosocomially, and independently increase acute-on-chronic liver failure risk, according to the American Association for the Study of Liver Diseases 1
• Antibiotic use causes gut fungal dysbiosis, necessitating antifungal coverage consideration in non-responders, as recommended by the American Association for the Study of Liver Diseases 1